CENEXEL Trademark

Trademark Overview

On Wednesday, February 27, 2019, a trademark application was filed for CENEXEL with the United States Patent and Trademark Office. The USPTO has given the CENEXEL trademark a serial number of 88318336. The federal status of this trademark filing is REGISTERED as of Tuesday, November 23, 2021. This trademark is owned by JBR Clinical Research, Inc.. The CENEXEL trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical and Scientific research and development services; Pharmaceutical products development; Pharmaceutical drug development services; Clinical research in the field of medicine, therapeutics and pharmaceutical development, namely, psychiatry, neurology, analgesia, metabolic diseases and disorders, endocrinology, dermatology, infectious diseases, and women's health; Conducting clinical trials for others; Drug discovery services; Consulting services in the field of pharmaceutical research and development; research and development services in the fields of psychiatry, neurology, analgesia, metabolic diseases and disorders, endocrinology, dermatology, infectious diseases, and women's health; consulting services for others in the field of design, planning, and implementation project management of clinical trials
cenexel

General Information

Serial Number88318336
Word MarkCENEXEL
Filing DateWednesday, February 27, 2019
Status700 - REGISTERED
Status DateTuesday, November 23, 2021
Registration Number6569746
Registration DateTuesday, November 23, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 2, 2019

Trademark Statements

Goods and ServicesPharmaceutical and Scientific research and development services; Pharmaceutical products development; Pharmaceutical drug development services; Clinical research in the field of medicine, therapeutics and pharmaceutical development, namely, psychiatry, neurology, analgesia, metabolic diseases and disorders, endocrinology, dermatology, infectious diseases, and women's health; Conducting clinical trials for others; Drug discovery services; Consulting services in the field of pharmaceutical research and development; research and development services in the fields of psychiatry, neurology, analgesia, metabolic diseases and disorders, endocrinology, dermatology, infectious diseases, and women's health; consulting services for others in the field of design, planning, and implementation project management of clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 19, 2019
Primary Code042
First Use Anywhere DateTuesday, April 30, 2019
First Use In Commerce DateTuesday, April 30, 2019

Trademark Owner History

Party NameCENEXEL CLINICAL RESEARCH, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressMURRAY, UT 84107
Party NameCENEXEL CLINICAL RESEARCH, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressMURRAY, UT 84107
Party NameJBR Clinical Research, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84107
Party NameJBR Clinical Research, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84107

Trademark Events

Event DateEvent Description
Tuesday, November 23, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, October 19, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 18, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, October 11, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 11, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 11, 2021TEAS REQUEST FOR RECONSIDERATION RECEIVED
Thursday, April 29, 2021NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 29, 2021FINAL REFUSAL E-MAILED
Thursday, April 29, 2021SU - FINAL REFUSAL - WRITTEN
Tuesday, April 6, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 6, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 30, 2021ASSIGNED TO LIE
Wednesday, March 24, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 28, 2020NON-FINAL ACTION E-MAILED
Monday, September 28, 2020SU - NON-FINAL ACTION - WRITTEN
Tuesday, September 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 31, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, August 21, 2020USE AMENDMENT FILED
Monday, August 31, 2020EXTENSION 2 GRANTED
Friday, August 21, 2020EXTENSION 2 FILED
Monday, August 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, August 21, 2020TEAS EXTENSION RECEIVED
Friday, August 21, 2020TEAS STATEMENT OF USE RECEIVED
Friday, February 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 26, 2020EXTENSION 1 GRANTED
Wednesday, February 26, 2020EXTENSION 1 FILED
Wednesday, February 26, 2020TEAS EXTENSION RECEIVED
Monday, February 10, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, October 23, 2019AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, August 27, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 16, 2019ASSIGNED TO EXAMINER
Tuesday, July 2, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 12, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 29, 2019LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 29, 2019ASSIGNED TO LIE
Wednesday, May 15, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 14, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, May 14, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 14, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, May 14, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 8, 2019ASSIGNED TO EXAMINER
Tuesday, March 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 2, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

cenexel development services pharmaceutical diseases research field clinical infectious dermatology women